Ventripoint Single Ventricle Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT05262907

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05262907
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05262907. Non-randomized; no masking; primary purpose diagnostic. Start 2022-07-08 (actual); primary completion 2027-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ventripoint Single Ventricle Study
Condition
Congenital Heart Disease
Condition
Single-ventricle
Intervention (Device)
Transthoracic Echocardiogram or Cardiac MRI
Intervention (Device)
Ventripoint Echocardiogram
Lead sponsor
Duke University (class: other)

Record details

Record id
cardio:ct-nct05262907
Content hash
ac05914bb0945a9956e9f6ae9ec9f8595780ebf04c26db4f535d86cee9c192b3